MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/js9.0000000000004752

Медицинская библиотека · International journal of surgery (London, England) · 2026

Survival and safety outcomes of hepatectomy versus ablation in hepatocellular carcinoma within Milan criteria and clinically significant portal hypertension: a systematic review and meta-analysis.

Wen Yong-Hao, Yang Yu-Min, Yan Jing-Xin, Gu Peng, Tai Yan-Qi, Li Jin-Yu, Duan Yun-Long, Deng Man-Jun, Fan Hai-Ning

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The applicability and safety of hepatectomy in hepatocellular carcinoma (HCC) patients with clinically significant portal hypertension (CSPH) remain controversial. This study aimed to compare the safety and long-term outcomes of hepatectomy versus ablation in HCC patients within the Milan criteria and concomitant CSPH.

MATERIALS AND

METHODS

Following the PRISMA 2020 guidelines, a systematic literature search was conducted across PubMed, Cochrane, and other databases from inception to 20 April 2025. AI-assisted screening was performed using AS Review. Meta-analysis was conducted using R software (v4.4.1). Fixed-effect or random-effect models were used to calculate the comprehensive effect magnitude for overall survival (OS) and recurrence-free survival (RFS). Sparse Bayesian meta-analysis was applied to postoperative complications. Individual patient data (IPD) reconstruction validated survival outcomes.

RESULTS

Seven studies (1 RCT, 6 retrospective) involving 972 patients were included. Pooled analysis showed no significant difference in OS between ablation and hepatectomy (HR = 1.10, 95% CI: 0.76-1.61, P = 0.644), but hepatectomy significantly improved RFS (HR = 2.05, 95% CI: 1.54-2.71, P < 0.001). Adjusted analyses revealed nonsignificant RFS differences (HR = 1.63, 95% CI: 0.85-3.13, P = 0.151). Subgroup analysis demonstrated superior RFS with hepatectomy versus radiofrequency ablation (HR = 2.01, 95% CI: 1.18-3.42, P = 0.008), though OS remained comparable. Notably, hepatectomy conferred dual benefits in hepatitis B virus (HBV)-related HCC for both OS (HR = 1.45, P = 0.016) and RFS (HR = 1.90, P = 0.006). IPD reconstruction further supported hepatectomy's RFS advantage (HR = 1.81, P < 0.001). Ablation was associated with lower overall complication risks, particularly a 69% reduction in ascites (OR = 0.31).

CONCLUSIONS

This study suggests that the long-term survival rates of hepatectomy and ablation are comparable, but hepatectomy shows better recurrence control, especially in HBV-related cases.

Для цитирования: Wen Yong-Hao, Yang Yu-Min, Yan Jing-Xin, Gu Peng, Tai Yan-Qi, Li Jin-Yu, Duan Yun-Long, Deng Man-Jun, Fan Hai-Ning. Survival and safety outcomes of hepatectomy versus ablation in hepatocellular carcinoma within Milan criteria and clinically significant portal hypertension: a systematic review and meta-analysis.. International journal of surgery (London, England). 2026. DOI: 10.1097/js9.0000000000004752.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.